3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Phase 1/2
1
Status
Completed
2
Terminated
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
3
Tumor-Agnostic
1
Sarcoma
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Interventions
Carboplatin
110
pembrolizumab
92
Pemetrexed
84
Cisplatin
69
Specimen Handling
40
Paclitaxel
36
durvalumab
35
Docetaxel
34
atezolizumab
33
Nivolumab
33
osimertinib
30
Magnetic Resonance Spectroscopy
29
Gemcitabine
22
Radiotherapy
20
Etoposide
20
130-nm albumin-bound paclitaxel
19
Cetuximab
16
amivantamab
14
Platinum
13
Bevacizumab
13
Radiosurgery
12
Radiation
12
lazertinib
11
Taxes
11
Ipilimumab
11
Immunoglobulin G
11
cemiplimab
10
Topotecan
10
Disulfides
10
1,2-diaminocyclohexaneplatinum II citrate
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Tiragolumab
×
Thoracic
×
30 days
×
Clear all
NCT04513925
2026-06-03
SKYSCRAPER-03
Hoffmann-La Roche
Phase 3
Completed
829 enrolled
40 charts
NCT04619797
2026-06-03
SKYSCRAPER-06
Hoffmann-La Roche
Phase 2/3
Completed
542 enrolled
28 charts
NCT03337698
2026-05-12
Morpheus Lung
Hoffmann-La Roche
Phase 1/2
Terminated
314 enrolled
31 charts